V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 200006253 | 200014718 | 1.6 | 95.6 | Palliative (P) | 2016-12-18 | 2017-05-04 | IPILIMUMAB + NIVOLUMAB | 02 | null | IPILIMUMAB + NIVOLUMAB | 100927027 |
| 200006254 | 200014719 | 1.76 | 86.7 | Palliative (P) | 2020-10-06 | 2020-10-06 | Trial Unspecified | N | null | DABRAFENIB | 101098756 |
| 200006256 | 200014720 | 1.68 | 81.8 | Palliative (P) | null | 2022-04-18 | null | null | null | COMBI-AD TRIAL | 100327052 |
| 200006257 | 200014721 | 1.6 | 63.5 | Palliative (P) | 2018-09-26 | 2018-09-29 | IPILIMUMAB + NIVOLUMAB | 02 | N | IPILIMUMAB + NIVOLUMAB | 101852285 |
| 200006262 | 200014724 | null | null | null | null | 2020-12-01 | null | null | null | DACARBAZINE | 100239813 |
| 200006264 | 200014725 | 1.79 | 70.8 | Palliative (P) | 2018-05-12 | 2018-05-26 | IPILIMUMAB + NIVOLUMAB | 02 | N | IPILIMUMAB + NIVOLUMAB | 101600683 |
| 200006267 | 200014727 | null | 109.9 | Palliative (P) | 2019-09-02 | 2019-09-06 | DABRAFENIB | 02 | N | DABRAFENIB | 101002006 |
| 200006269 | 200014728 | 1.69 | 92.85 | Palliative (P) | 2018-06-29 | 2019-07-16 | IPILIMUMAB + NIVOLUMAB | 02 | null | IPILIMUMAB + NIVOLUMAB | 100503779 |
| 200006270 | 200014729 | 1.85 | 64 | Palliative (P) | 2017-09-24 | 2017-10-24 | IPILIMUMAB + NIVOLUMAB | 02 | N | IPILIMUMAB + NIVOLUMAB | 101866427 |
| 200006271 | 200014730 | null | 95.5 | Palliative (P) | 2017-12-18 | 2017-12-18 | IPILIMUMAB + NIVOLUMAB | 02 | N | IPILIMUMAB + NIVOLUMAB | 100804969 |
| 200006278 | 200014733 | 1.55 | 74 | Palliative (P) | 2018-08-29 | 2018-09-12 | IPILIMUMAB + NIVOLUMAB | 02 | null | IPILIMUMAB + NIVOLUMAB | 101564127 |
| 200006280 | 200014734 | 1.74 | 65.55 | Palliative (P) | 2017-11-09 | 2017-11-09 | null | N | null | IPILIMUMAB + NIVOLUMAB | 101346567 |
| 200006282 | 200014735 | 1.81 | 57.7 | Palliative (P) | 2016-02-29 | 2016-03-28 | IPILIMUMAB + NIVOLUMAB | 02 | null | TRIAL UNSPECIFIED | 100865135 |
| 200006283 | 200014736 | 1.65 | 71 | Palliative (P) | null | 2020-12-03 | null | null | N | BINIMETINIB + ENCORAFENIB | 101855769 |
| 200006285 | 200014737 | null | 120.2 | Palliative (P) | 2018-08-25 | 2018-08-30 | DABRAFENIB | 02 | null | TRIAL UNSPECIFIED | 100382654 |
| 200006286 | 200014738 | 1.51 | 66.2 | Palliative (P) | 2016-11-07 | 2016-11-20 | Carboplatin + Paclitaxel (3 weekly) | 02 | null | IPILIMUMAB + NIVOLUMAB | 100842622 |
| 200006292 | 200014744 | 1.59 | 75.9 | Palliative (P) | 2019-08-24 | 2019-08-25 | IPILIMUMAB + NIVOLUMAB | 02 | null | IPILIMUMAB + NIVOLUMAB | 100514649 |
| 200006293 | 200014745 | 2.14 | 116.9 | Palliative (P) | 2021-08-11 | 2021-08-22 | IPILIMUMAB + NIVOLUMAB | 02 | N | IPILIMUMAB + NIVOLUMAB | 100366768 |
| 200006294 | 200014746 | 0 | 0 | Palliative (P) | 2021-01-01 | 2021-08-08 | DABRAFENIB | 02 | null | DABRAFENIB | 100777524 |
| 200006295 | 200014747 | 1.74 | 95.5 | null | 2021-05-02 | 2021-05-26 | IPILIMUMAB + NIVOLUMAB | 02 | null | IPILIMUMAB + NIVOLUMAB | 101831974 |
| 200006296 | 200014748 | 1.69 | 67.7 | Palliative (P) | 2020-01-21 | 2020-01-23 | IPILIMUMAB + NIVOLUMAB | 02 | N | IPILIMUMAB + NIVOLUMAB | 100441635 |
| 200006298 | 200014749 | 1.79 | 112 | Adjuvant (A) | 2017-11-02 | 2017-11-05 | Ipilimumab | N | N | IPILIMUMAB + NIVOLUMAB | 101335064 |
| 200006299 | 200014750 | 1.66 | 62 | 03 | 2022-02-17 | 2022-03-17 | DABRAFENIB | 02 | null | DABRAFENIB | 100596271 |
| 200006300 | 200014751 | 1.5 | 87.35 | null | 2017-12-20 | 2017-12-20 | IPILIMUMAB + NIVOLUMAB | 02 | null | IPILIMUMAB + NIVOLUMAB | 100063766 |
| 200006304 | 200014754 | 1.76 | 70 | Palliative (P) | 2019-01-05 | 2019-01-05 | DABRAFENIB | 02 | null | DABRAFENIB | 100169903 |
| 200006305 | 200014755 | 1.85 | 114.4 | Palliative (P) | 2017-05-27 | 2017-06-07 | Trial Unspecified | 02 | null | TRIAL UNSPECIFIED | 100235001 |
| 200006307 | 200014756 | 1.63 | 70.9 | Palliative (P) | 2017-10-30 | 2018-01-17 | null | 02 | null | DABRAFENIB | 101639873 |
| 200006308 | 200014757 | 1.63 | 87.9 | Palliative (P) | 2019-09-09 | 2019-09-18 | Ipilimumab | 02 | null | IPILIMUMAB | 100480681 |
| 200006309 | 200014758 | 1.75 | 63 | null | null | 2018-11-08 | Dacarbazine | 02 | N | IPILIMUMAB + NIVOLUMAB | 101089731 |
| 200006310 | 200014759 | 1.6 | 59.1 | Palliative (P) | 2017-08-26 | 2017-08-28 | IPILIMUMAB + NIVOLUMAB | 02 | null | IPILIMUMAB + NIVOLUMAB | 101165364 |
| 200006315 | 200014764 | 1.59 | 82.9 | Adjuvant (A) | 2019-07-10 | 2019-07-24 | IPILIMUMAB + NIVOLUMAB | 02 | null | IPILIMUMAB + NIVOLUMAB | 100046365 |
| 200006316 | 200014765 | 0 | 0 | Palliative (P) | 2016-06-26 | 2016-07-13 | IPILIMUMAB + NIVOLUMAB | 02 | N | IPILIMUMAB + NIVOLUMAB | 100843106 |
| 200006319 | 200014767 | null | 66.6 | null | 2018-10-29 | 2018-11-14 | Dacarbazine | 02 | null | DABRAFENIB | 100021003 |
| 200006320 | 200014768 | 1.51 | 98.8 | Palliative (P) | null | 2017-08-11 | null | null | null | BINIMETINIB + ENCORAFENIB | 100423081 |
| 200006322 | 200014769 | 1.78 | 89.4 | Palliative (P) | 2019-12-10 | 2020-10-15 | IPILIMUMAB + NIVOLUMAB | 01 | null | TRIAL UNSPECIFIED | 100439382 |
| 200006325 | 200014770 | null | 91 | Palliative (P) | 2016-10-16 | 2017-01-08 | DABRAFENIB | 02 | null | DABRAFENIB | 100406898 |
| 200006326 | 200014771 | 1.72 | 59.65 | null | 2021-02-11 | 2021-10-24 | Trial Unspecified | 01 | null | TRIAL UNSPECIFIED | 101796085 |
| 200006329 | 200014772 | 1.7 | 67 | Palliative (P) | 2019-07-12 | 2019-07-25 | null | 02 | null | DABRAFENIB | 101808118 |
| 200006331 | 200014773 | 0 | 0 | Palliative (P) | 2022-02-23 | 2022-02-23 | DABRAFENIB | 02 | null | DABRAFENIB | 100994031 |
| 200006335 | 200014776 | null | 107.1 | Palliative (P) | null | 2019-05-05 | Ipilimumab | null | null | IPILIMUMAB | 101736131 |
| 200006337 | 200014777 | null | 87.7 | Palliative (P) | 2017-05-29 | 2017-05-29 | IPILIMUMAB + NIVOLUMAB | 02 | null | IPILIMUMAB + NIVOLUMAB | 101377656 |
| 200006338 | 200014778 | 1.71 | 73.9 | Palliative (P) | 2017-07-17 | 2017-07-17 | IPILIMUMAB + NIVOLUMAB | 02 | N | IPILIMUMAB + NIVOLUMAB | 100810821 |
| 200006340 | 200014779 | 1.58 | 168.8 | Palliative (P) | 2018-11-28 | 2018-12-01 | DABRAFENIB | 02 | null | DABRAFENIB | 101092561 |
| 200006343 | 200014781 | 1.82 | 120.2 | null | 2019-06-22 | 2019-06-22 | IPILIMUMAB + NIVOLUMAB | 02 | null | IPILIMUMAB + NIVOLUMAB | 100049485 |
| 200006344 | 200014782 | 1.73 | 54.4 | Adjuvant (A) | null | 2016-03-25 | null | null | null | DOCETAXEL | 101402562 |
| 200006345 | 200014783 | 1.64 | 83.5 | Palliative (P) | 2019-09-14 | 2019-09-29 | DABRAFENIB | 02 | null | DABRAFENIB | 101734354 |
| 200006346 | 200014784 | null | 120.2 | null | null | 2019-06-20 | null | null | null | BINIMETINIB + ENCORAFENIB | 101185765 |
| 200006347 | 200014785 | 1.71 | 83.4 | Palliative (P) | 2019-02-13 | 2019-07-20 | Carboplatin + Paclitaxel (3 weekly) | 02 | null | TRIAL UNSPECIFIED | 101284535 |
| 200006351 | 200014788 | 1.65 | 65 | Palliative (P) | 2018-06-14 | 2018-11-21 | Trametinib | 02 | null | DABRAFENIB | 100120561 |
| 200006354 | 200014791 | 1.71 | 77 | Palliative (P) | 2020-10-01 | 2020-10-01 | IPILIMUMAB + NIVOLUMAB | 02 | null | IPILIMUMAB + NIVOLUMAB | 100576018 |